Clinical course of patients with WASP gene mutations

Blood

Volumn 103, Issue 2, 2004, Pages 456-464

  Imai, Kohsuke ^a   Morio, Tomohiro ^b   Zhu, Yi ^b   Jin, Yinzhu ^b   Itoh, Sukeyuki ^b   Kajiwara, Michiko ^b   Yata, Jun Ichi ^b   Mizutani, Shuki ^b   Ochs, Hans D ^b   Nonoyama, Shigeaki ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

WISKOTT ALDRICH SYNDROME PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; BRAIN HEMORRHAGE; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; DEATH; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; ECZEMA; GASTROINTESTINAL HEMORRHAGE; GENE DELETION; GENE INSERTION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; JAPAN; MALIGNANT NEOPLASTIC DISEASE; MISSENSE MUTATION; MYCOSIS; NONSENSE MUTATION; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; VIRUS INFECTION; WISKOTT ALDRICH SYNDROME; X CHROMOSOME LINKED DISORDER;

EID: 9144241005     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-05-1480     Document Type: Article

References (34)

1. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr. 1994;125:876-885.
2. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 1994;78:635-644. Erratum in: Cell. 1994;799:922.
3. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 1994;78:635-644. Erratum in: Cell. 1994;799:922.
4. Nonoyama S, Ochs HD. Wiskott-Aldrich syndrome. Curr Allergy Asthma Rep. 2001;1:430-437.
5. Ochs HD. The Wiskott-Aldrich syndrome. Semin Hematol. 1998;35:332-345.
6. Thrasher AJ. WASp in immune-system organization and function. Nat Rev Immunol. 2002;2:635-646.
7. Villa A, Notarangelo L, Macchi P, et al. X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet. 1995;9:414-417.
8. Zhu Q, Zhang M, Blaese RM, et al. The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene. Blood. 1995;86:3797-3804.
9. Wengler GS, Notarangelo LD, Berardelli S, et al. High prevalence of nonsense, frame shift, and splice-site mutations in 16 patients with full-blown Wiskott-Aldrich syndrome. Blood. 1995;86:3648-3654.
10. Zhu QL, Watanabe C, Liu T, et al. Wiskott-Aldrich syndrome/X-linked thrombocytopenia-WASP gene mutations, protein expression, and phenotype. Blood. 1997;90:2680-2689.
11. Lemahieu V, Gastier JM, Francke U. Novel mutations in the Wiskott-Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes. Hum Mutat. 1999;14:54-66.
12. Schindelhauer D, Weiss M, Hellebrand H, et al. Wiskott-Aldrich syndrome: no strict genotype-phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product. Hum Genet. 1996;98:68-76.
13. Itoh S, Nonoyama S, Modo T, et al. Mutations of the WASP gene in 10 Japanese patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia. Int J Hematol. 2000;71:79-83.
14. Kawakami C, Miyake M, Tamai H. Kawasaki disease in a patient with Wiskott-Aldrich syndrome: an increase in the platelet count. Int J Hematol. 2003;77:199-200.
15. Inoue H, Kurosawa H, Nonoyama S, et al. X-linked thrombocytopenia in a girl. Br J Haematol. 2002;118:1163-1165.
16. Ochs HD. The Wiskott-Aldrich syndrome. Isr Med Assoc J. 2002;4:379-384.
17. Hagemann TL, Mares D, Kwan S. Gene regulation of Wiskott-Aldrich syndrome protein and the human homolog of the Drosophila Su(var)3-9: WASP and SUV39H1, two adjacent genes at Xp11.23. Biochim Biophys Acta. 2000;1493:368-372.
18. Gustafsson D, Sjoberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis - a prospective follow-up to 7 years of age. Allergy. 2000;55:240-245.
19. Yoshida K, Minegishi Y, Okawa H, et al. Epstein-Barr virus-associated malignant lymphoma with macroamylasemia and monoclonal gammopathy in a patient with Wiskott-Aldrich syndrome. Pediatr Hematol Oncol. 1997;14:85-89.
20. Schwarz K, Nonoyama S, Peitsch MC, et al. WASPbase - a database of WAS- and XLT-causing mutations. Immunol Today. 1996;17:496-502.
21. Molina IJ, Sancho J, Terhorst C, Rosen FS, Remold-O'Donnell E. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J Immunol. 1993;151:4383-4390.
22. Ochs HD, Slichter SJ, Harker LA, Von Behrens WE, Clark RA, Wedgwood RJ. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood. 1980;55:243-252.
23. Ochs HD, Rosen FS. The Wiskott-Aldrich syndrome. In: Ochs HD, Puck J, Smith CIE, eds. Primary Immunodeficiency Diseases: A Molecular and Genetic Approach. New York, NY: Oxford University Press; 1999:292-305.
24. Spitler LE, Wray BB, Mogerman S, Miller JD, O'Reilly RJ, Lagios M. Nephropathy in the Wiskott-Aldrich syndrome. Pediatrics. 1980;66:391-398.
25. DeSanto NG, Sessa A, Capodicasa G, et al. IgA glomerulonephritis in Wiskott-Aldrich syndrome. Child Nephrol Urol. 1988;9:118-120.
26. Bennett CP, Barnicoat AJ, Cotter F, Wang Q, Mathew CG. A variant of Wiskott-Aldrich syndrome with nephropathy is linked to DXS255 [letter]. J Med Genet. 1995;32:757-758.
27. Duzova A, Topaloglu R, Sanal O, et al. Henoch-Schonlein purpura in Wiskott-Aldrich syndrome. Pediatr Nephrol. 2001;16:500-502.
28. Huang MM, Tsuboi S, Wong A, et al. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins. Gene Ther. 2000;7:314-320.
29. Allen AC, Feehally J. IgA1 glycosylation and the pathogenesis of IgA nephropathy. Am J Kidney Dis. 2000;35:551-556.
30. Remold-O'Donnell E, Cooley J, Shcherbina A, et al. Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients. J Immunol. 1997;158:4021-4025.
31. Wada T, Schurman SH, Otsu M, et al. Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc Natl Acad Sci U S A. 2001;98:8697-8702.
32. Ariga T, Kondoh T, Yamaguchi K, et al. Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome. J Immunol. 2001;166:5245-5249.
33. Filipovich AH, Stone JV, Tomany SC, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood. 2001;97:1598-1603.
34. Mullen CA, Anderson KD, Blaese RM. Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 cases. Blood. 1993;82:2961-2966.